Interactions between NCR⁺ILC3s and the Microbiome in the Airways Shape Asthma Severity

Abstract

Asthma is a heterogeneous disease whose development is shaped by a variety of environmental and genetic factors. While several recent studies suggest that microbial dysbiosis in the gut may promote asthma, little is known about the relationship between the recently discovered lung microbiome and asthma. Innate lymphoid cells (ILCs) have also been shown recently to participate in asthma. To investigate the relationship between the lung microbiome, ILCs, and asthma, we recruited 23 healthy controls (HC), 42 patients with non-severe asthma, and 32 patients with severe asthma. Flow cytometry analysis showed severe asthma associated with fewer natural cytotoxicity receptor (NCR) + ILC3s in the lung. Similar changes in other ILC subsets, macrophages, and monocytes were not observed. The asthma patients did not differ from the HC in terms of the alpha and beta-diversity of the lung and gut microbiomes. However, lung function correlated positively with both NCR + ILC3 frequencies and microbial diversity in the lung. Sputum NCR + ILC3 frequencies correlated positively with lung microbiome diversity in the HC, but this relationship was inversed in severe asthma. Together, these data suggest that airway NCR + ILC3s may contribute to a healthy commensal diversity and normal lung function.

The role of innate lymphoid cells in chronic rhinosinusitis severity in children: a cross-sectional study

“…We observed a negative relationship between ILC3 levels and bacterial richness, as measured by OTU in nasal scrapings. This finding supports previous research showing that ILC3 is a marker of dysbiosis [30,31]. However, because increased ILC3 levels were associated with lower bacterial richness, they did not significantly affect the clinical severity of chronic rhinosinusitis.…”

Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells

“…ILC3s are divided into 2 subtypes depending on their expression of the NCR NKp46, and NCR - ILC3s are known to predominantly produce IL-17 in the presence of IL-1β 47 . Although these cells are less clearly defined in asthma, recent studies have revealed the contribution of ILC3s to lung dysfunction and asthma severity 48 . Moreover, the proliferation of IL-17-producing ILC3s induced by NLRP3 activation in the lungs was suggested to directly drive airway hyperresponsiveness, which was ameliorated by the blockade of IL-1β 49 .…”

Winds of change a tale of: asthma and microbiome

“…Airway microbiota similar to asthmatic patients. No differences in airway diversity between asthmatic patients and healthy controls in the composition of microbiota (Ham et al, 2021).…”